Literature DB >> 28652454

Hepatic Epithelioid Hemangioendothelioma - a Rare Tumor and Diagnostic Dilemma.

Vladislav Treska1, Ondrej Daum2, Martin Svajdler2, Vaclav Liska3, Jiri Ferda4, Jan Baxa4.   

Abstract

BACKGROUND/AIM: Hepatic epithelioid haemangio-endothelioma (HEHE) is a very rare malignant tumor of vascular origin and uncertain biological behaviour that is difficult to diagnose using preoperative radiology diagnostic techniques. PATIENTS AND METHODS: The authors present here two patients with HEHE of different extent. The first patient had a generalised form of disease, with involvement of the liver, lungs and bones and was treated with a combination of bevacizumab and capecitabine. The second patient had a localised form of disease involving the liver and this was resolved using a combination of liver resection and radiofrequency ablation. In both patients, the radiology work-up before surgery was non-specific and metastases of another malignant process were considered. The definitive histological diagnosis was made by the pathologist on the basis of immunohistochemical analysis that demonstrated the presence of CD31, CD34 and calmodulin-binding transcription activator 1 (CAMTA 1).
RESULTS: Both patients remain in an overall good condition 27 and 5 months respectively following treatment for HEHE.
CONCLUSION: Preoperative radiological diagnosis of HEHE is difficult and immunohistochemical examination of the tumor tissue sample remains the key diagnostic tool. Radical surgical resection or liver transplantation is the method of choice in patients with localised liver involvement. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Hepatic epithelioid haemangioendothelioma; diagnostic dilemma; treatment options

Mesh:

Substances:

Year:  2017        PMID: 28652454      PMCID: PMC5566937          DOI: 10.21873/invivo.11128

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  12 in total

1.  Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma.

Authors:  Seda Laçın; Ozlem Küçük; Ilker Oz; Sadık Bılgıç
Journal:  Turk J Gastroenterol       Date:  2011-02       Impact factor: 1.852

Review 2.  Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.

Authors:  Augustine Lau; Steve Malangone; Myke Green; Ambuga Badari; Kathryn Clarke; Emad Elquza
Journal:  Ther Adv Med Oncol       Date:  2015-07       Impact factor: 8.168

Review 3.  Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma.

Authors:  Akshitkumar M Mistry; D Lee Gorden; Jacob F Busler; Alice C Coogan; Beau S Kelly
Journal:  J Gastrointest Cancer       Date:  2012-12

4.  Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases.

Authors:  K G Ishak; I A Sesterhenn; Z D Goodman; L Rabin; F W Stromeyer
Journal:  Hum Pathol       Date:  1984-09       Impact factor: 3.466

5.  Hepatic epithelioid haemangioendothelioma: challenges in diagnosis and management.

Authors:  L W Y Thin; D D Wong; B W De Boer; J M Ferguson; L Adams; G Macquillan; L Delriviere; A Mitchell; G P Jeffrey
Journal:  Intern Med J       Date:  2010-10       Impact factor: 2.048

6.  Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation.

Authors:  Piotr Remiszewski; Ewa Szczerba; Piotr Kalinowski; Beata Gierej; Krzysztof Dudek; Mariusz Grodzicki; Marcin Kotulski; Rafał Paluszkiewicz; Waldemar Patkowski; Krzysztof Zieniewicz; Marek Krawczyk
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.

Authors:  Leona A Doyle; Christopher D M Fletcher; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

8.  Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma.

Authors:  Ryan M Thomas; Thomas A Aloia; Mark J Truty; Warren H Tseng; Eugene A Choi; Steven A Curley; Jean N Vauthey; Eddie K Abdalla
Journal:  HPB (Oxford)       Date:  2013-12-06       Impact factor: 3.647

9.  Long term follow up after resection emphasizes the role of surgery in Primary Hepatic Epithelioid Hemangioendothelioma.

Authors:  Arianeb Mehrabi; Katrin Hoffmann; Karl Heinz Weiss; Carolin Mogler; Peter Schemmer; Markus W Büchler; Ingo Alldinger
Journal:  Ann Med Surg (Lond)       Date:  2016-03-10

10.  Hepatic epithelioid hemangioendothelioma: Dilemma and challenges in the preoperative diagnosis.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Qiu-Yang Jing; Anuj Shrestha; Nan-Sheng Cheng; Fu-Yu Li
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

View more
  10 in total

1.  Hepatic epithelioid hemangioendothelioma after thirteen years' follow-up: A case report and review of literature.

Authors:  Wei-Fang Mo; Yu-Ling Tong
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

2.  Triple whammy: a rare case of epithelioid hemangioendothelioma with synchronous angiomyomatous hamartoma complicated by Actinomyces meyeri.

Authors:  Nariman Khan; Saadia Waheed; Rahaf Alkhateb
Journal:  Arch Clin Cases       Date:  2021-12-29

3.  Hepatic epitheloid haemangioendothelioma: a rare malignant tumour.

Authors:  Pernille Strecker Lund; Gro Linno Willemoe; Lasse Bremholm Hansen; Mads Warnecke
Journal:  BMJ Case Rep       Date:  2020-01-28

4.  Metastatic Hepatic Epitheloid Hemangioendothelioma in a Young Male: A Rare Presentation.

Authors:  Tanweerul Huda; Mohammad Masoom Parwez; Bharati Pandya
Journal:  Gastrointest Tumors       Date:  2021-02-18

5.  Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience.

Authors:  Linping Cao; Jiawei Hong; Lingfeng Zhou; Yufu Ye; Yuanxing Liu; Jun Yu; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2019-11-07       Impact factor: 2.754

6.  Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?

Authors:  Anastasios Kyriazoglou; Konstantinos Koutsoukos; Flora Zagouri; Michalis Liontos; Efthimios Dimitriadis; Dina Tiniakos; Meletios Athanasios Dimopoulos
Journal:  Ther Clin Risk Manag       Date:  2020-02-27       Impact factor: 2.423

7.  Hepatic epithelioid hemangioendothelioma simulating liver metastasis: A case report.

Authors:  Badr Serji; Abdelbassir Ramdani; Houda Mirali; Tariq Bouhout; Amal Bennani; Tijani El Harroudi
Journal:  Ann Med Surg (Lond)       Date:  2021-09-22

8.  Three cases of hepatic epithelioid hemangioendothelioma evaluated using conventional and contrast-enhanced ultrasound: Case reports.

Authors:  Jian-Qiang Fang; Ya-Yun Ji; Wei-An Zhao; Cui Pu; Si-Yuan Mi; Bin-Yu Zhang
Journal:  J Clin Ultrasound       Date:  2022-01-12       Impact factor: 0.869

9.  Surgical treatment of asymptomatic epithelioid hemangioendothelioma originating from the superior vena cava: A case report.

Authors:  Seok Soo Lee; Jang Hoon Lee
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

10.  Hepatic epithelioid hemangioendothelioma: case series of a rare vascular tumor mimicking metastases.

Authors:  Nasir Ud Din; Shabina Rahim; Tamana Asghari; Jamshid Abdul-Ghafar; Zubair Ahmad
Journal:  Diagn Pathol       Date:  2020-09-25       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.